<div id="readability-page-1"><p>In a report released today, Thibault Boutherin from Morgan Stanley maintained a Buy rating on Lonza Group Ltd, with a price target of <span id="expert-recommendation-target">CHF650.00</span>.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Boutherin covers the Healthcare sector, focusing on stocks such as Novartis AG, Lonza Group Ltd, and Alvotech. According to TipRanks, Boutherin has an average return of <span>3.9%</span> and a 49.06% success rate on recommended stocks. </p> <p>Lonza Group Ltd has an analyst consensus of Strong Buy, with a price target consensus of CHF674.60.</p></div>

<p>Morgan Stanley's Thibault Boutherin maintains a Buy rating on Lonza Group Ltd with a price target of CHF650.00. Boutherin, focusing on healthcare stocks, has an average return of 3.9% and a 49.06% success rate. Lonza Group Ltd has a Strong Buy consensus with a price target of CHF674.60.</p>

Morgan Stanley Keeps Their Buy Rating on Lonza Group Ltd (LONN)